Showing results (71-80 of 148) with videos related to
Sort By:
Pageof 15
Environmental Science & Technology|February 12, 2025
Utilizing Internet Search Trends and Wastewater Surveillance to Identify Infectious Disease Outbreaks in CommunitiesAlessandro Zulli, Zoe Zhang, Madelena Ruedaflores, et al.Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.The New England Journal of Medicine|November 19, 2010
Safety of anacetrapib in patients with or at high risk for coronary heart diseaseChristopher P Cannon, Sukrut Shah, Hayes M Dansky, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 17, 2014
Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE studyAntonio M Gotto, Uma Kher, Manash Shankar Chatterjee, et al.Diabetes|March 31, 2007
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factorNaveed Sattar, Alex McConnachie, Ian Ford, et al.Circulation|October 30, 2007
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countriesBeverley Balkau, John E Deanfield, Jean-Pierre Després, et al.Journal of the American College of Cardiology|April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.Lancet (London, England)|January 16, 2007
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control studyScott W Brouilette, Jasbir S Moore, Alex D McMahon, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.Circulation. Cardiovascular Genetics|December 3, 2011
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studiesBenoit J Arsenault, S Matthijs Boekholdt, G Kees Hovingh, et al.Pageof 15